Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
13 November 2023Website:
http://cargo-tx.comNext earnings report:
13 December 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 20:03:13 GMTDividend
Analysts recommendations
Institutional Ownership
CRGX Latest News
The cancer-focused biotech published its second-quarter results. Its loss was much narrower than analysts had expected.
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
SAN CARLOS, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced that the company will be participating in the following investor conferences.
CARGO Therapeutics, Inc. (CRGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The consensus price target hints at a 56.3% upside potential for CARGO Therapeutics, Inc. (CRGX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
SAN MATEO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced that the company will participate in the 42nd Annual J.P. Morgan Healthcare Conference, taking place January 8-11, 2024, in San Francisco, California.
Cargo Therapeutics CRGX, , a clinical-stage biotech specializing in cancer treatments, said late Thursday its initial public offering priced at $15 a share, the low end of its range. The company sold 18.8 million shares to raise $282 million at a valuation of $580.5 million.
Cargo Therapeutics, Inc. has filed for an IPO to raise $300 million for the development of its drug candidates for large B cell lymphoma cancer and other B cell malignancies. The IPO appears reasonably priced, but biopharma IPOs have performed poorly in the recent IPO environment. The market for treatments of diffuse large B-cell lymphoma is expected to reach $7.9 billion by 2030, driving the growth of CARGO Therapeutics.
Cargo Therapeutics CRGX, , a clinical-stage biotech specializing in cancer treatments, set terms for its initial public offering early Monday with plans to offer 18.8 million shares priced at $15 to $17 each. The company would raise $319.6 million at the top of that range at a valuation of $656.2 million.
Cargo Therapeutics, Inc. has filed for a $100 million IPO to develop improved CAR T-cell therapy for large B-cell lymphoma. The company's lead candidate, CRG-022, is in Phase 2 trials for the treatment of Refractory/Relapsed LBCL. The market for treatments of diffuse large B-cell lymphoma is forecasted to reach $7.9 billion by 2030, so Cargo Therapeutics is operating in a moderately growing market.
What type of business is CARGO Therapeutics?
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.
What sector is CARGO Therapeutics in?
CARGO Therapeutics is in the Healthcare sector
What industry is CARGO Therapeutics in?
CARGO Therapeutics is in the Biotechnology industry
What country is CARGO Therapeutics from?
CARGO Therapeutics is headquartered in United States
When did CARGO Therapeutics go public?
CARGO Therapeutics initial public offering (IPO) was on 13 November 2023
What is CARGO Therapeutics website?
https://cargo-tx.com
Is CARGO Therapeutics in the S&P 500?
No, CARGO Therapeutics is not included in the S&P 500 index
Is CARGO Therapeutics in the NASDAQ 100?
No, CARGO Therapeutics is not included in the NASDAQ 100 index
Is CARGO Therapeutics in the Dow Jones?
No, CARGO Therapeutics is not included in the Dow Jones index
When was CARGO Therapeutics the previous earnings report?
No data
When does CARGO Therapeutics earnings report?
The next expected earnings date for CARGO Therapeutics is 13 December 2024